XML 30 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Revenue Recognition (Details) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Mar. 31, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Olympus and Olympus-Cytori [Member]
Sep. 30, 2012
BARDA Contract [Member]
Jun. 30, 2014
BARDA Contract [Member]
Jun. 30, 2014
Customer Concentration Risk [Member]
Revenue Recognized [Member]
Distributor
Jun. 30, 2013
Customer Concentration Risk [Member]
Revenue Recognized [Member]
Distributor
Customer
Jun. 30, 2014
Customer Concentration Risk [Member]
Accounts Receivable [Member]
Customer
Distributor
Jun. 30, 2013
Customer Concentration Risk [Member]
Accounts Receivable [Member]
Distributor
Customer
Jun. 30, 2014
North America [Member]
Jun. 30, 2013
North America [Member]
Jun. 30, 2014
Japan [Member]
Jun. 30, 2013
Japan [Member]
Jun. 30, 2014
Europe [Member]
Jun. 30, 2013
Europe [Member]
Jun. 30, 2014
Other countries [Member]
Jun. 30, 2013
Other countries [Member]
Revenue Recognition [Abstract]                                            
Period of services provided subsequent to date of sale       1 year                                    
Revenues from External Customers and Long-Lived Assets [Line Items]                                            
Number of distributors                     5 2 3 2                
Number of customers                       2 2 2                
Product revenues $ 935,000 $ 1,408,000   $ 1,965,000 $ 2,800,000                   $ 264,000 $ 583,000 $ 1,263,000 $ 1,487,000 $ 438,000 $ 625,000 $ 0 $ 105,000
Concentration risk percentage (in hundredths)       100.00% 100.00%           71.00% 38.00% 78.00% 58.00% 14.00% 21.00% 64.00% 53.00% 22.00% 22.00% 0.00% 4.00%
Research and Development Arrangements [Line Items]                                            
Deferred revenues, related party               28,311,000                            
Deferred revenue, related party, revenue recognized     638,000     0 2,882,000                              
Costs associated with the development device 4,674,000 4,150,000   8,966,000 7,869,000       106,000,000                          
Research and development arrangement with federal government, customer funding to offset costs incurred                 $ 4,700,000                          
Research and development arrangement, initial base period                   2 years